Ketamine for Depression: A New Era in Mental Health Treatment

Depression affects hundreds of millions of people worldwide and remains one of the leading causes of disability. While traditional antidepressants such as selective serotonin reuptake inhibitors (SSRIs) have helped many patients, they often require weeks to take effect and may not work for everyone. For individuals with treatment-resistant depression, ketamine therapy may be an effective alternative. 

At The Inner Divine, we offer ketamine-assisted psychotherapy (KAP) as part of an intentional, holistic healing journey. When combined with therapeutic support, ketamine can help open a window of neuroplasticity, allowing the opportunity to explore thoughts, emotions, and long-held patterns with a new perspective. Many people find that KAP opens doors to healing that traditional therapy couldn’t.

What Is Ketamine?

Ketamine is a dissociative anesthetic that has been widely used in surgery and emergency medicine. Unlike conventional antidepressants, which primarily target serotonin, norepinephrine, or dopamine systems, ketamine affects the brain's glutamate system—the most abundant excitatory neurotransmitter network in the brain.

Researchers believe ketamine blocks N-methyl-D-aspartate (NMDA) receptors, triggering a cascade of neurobiological changes that enhance synaptic plasticity, strengthen neural connections, and rapidly improve mood in some patients. This mechanism is fundamentally different from traditional antidepressants and may explain its unusually fast onset of action.

How Effective Is Ketamine for Depression?

One of the most remarkable findings in psychiatric research is ketamine's rapid antidepressant effect. A 2014 systematic review and meta-analysis of randomized controlled trials found that ketamine produced significant reductions in depressive symptoms and increased remission rates within 24 hours of treatment. Benefits were still evident several days after administration in many patients.

Another meta-analysis examining nine high-quality randomized controlled studies involving 368 patients reported that ketamine was significantly more effective than placebo at 24 hours, 72 hours, and seven days after treatment. Response rates exceeded 50% within the first day following treatment, an outcome rarely seen with conventional antidepressants.

These findings are especially important because traditional antidepressants often require four to six weeks before patients experience substantial improvement.